5 Stocks Under $10 Poised to Pop
Dara Biosciences
Another under-$10 name that's trending very close to triggering a near-term breakout trade is Dara Biosciences (DARA), a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. This stock has been in play to the upside during the last six months, with shares up by 23%.
If you take a look at the chart for Dara Biosciences, you'll notice that this stock recently formed a triple bottom chart pattern at 76 cents per share. Following that bottom, shares of DARA have started to move back above both its 50-day moving average at 81 cents per share and its 200-day moving average at 84 cents per share. That action is now quickly pushing DARA within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in DARA if it manages to break out above some near-term overhead resistance levels at 92 to 99 cents per share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 209,822 shares. If that breakout triggers soon, then DARA will set up to re-test or possibly take out its next major overhead resistance levels at $1.20 to $1.22 a share. Any high-volume move above those levels will then put $1.38 to $1.40 into range for shares of DARA.
Traders can look to buy DARA off any weakness to anticipate that breakout and then simply use a stop that sits right below its 50-day moving average of 81 cents per share. One could also buy DARA off strength once it clears those breakout levels with volume and then simply use a stop that sits just below 87 cents per share.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV